Oceanside, California USA, Feb 14 – AOTI Inc. announced today that it will again be providing an expansive Clinical Education program at the Desert Foot conference, East and Midwest Podiatric Residency summits, which are the leading conferences focused on the Veterans...
Oceanside, California USA, Aug 16 – AOTI Inc. announced today the U.S. Patent and Trademark Office have granted its Patent Application No. 14/150,178 – CONTROLLER FOR AN EXTREMITY HYPERBARIC DEVICE that will now issue as U.S. Patent No. 9,421,147. This is the...
Oceanside, California USA, Apr 16 – AOTI Inc. announced today the 10,000th patient has been treated with its revolutionary patented Topical Wound Oxygen Therapy. “This is a momentous milestone for our company and a testament to the clinical efficacy of TWO2 therapy,...
Oceanside, California USA, Jan 11 – AOTI Inc. announced today that it will be providing an expansive Clinical Education program at the Desert Foot conference, East and Midwest Podiatric Residency summits, which are the leading conferences focused on the Veterans...
Oceanside, California USA, Oct 13 – AOTI Inc. announced today that it is excited to again showcase its revolutionary Topical Wound Oxygen products at the upcoming Medica Expo in Dusseldorf, Germany from November 16-19. “Medica is one of the pre-eminent medical product...
Galway, Ireland, August 12 – AOTI Ltd. announced today that it will showcase its revolutionary wound care products at the upcoming Arab Health Expo in Dubai, UAE from January 25-28, 2016. “Arab Health is one of the pre-eminent medical product expos in the world”...
